Feldan is a leader in the field of recombinant protein production. Since its foundation in 2007, Feldan is profoundly engaged in the discovery, development, manufacturing and marketing of recombinant proteins designed to address research needs in life science. The company has been producing recombinant proteins and molecular biology reagents for life science companies and research laboratories around the world. Through these business opportunities, Feldan has acquired a high expertise in recombinant protein production and a solid track record in hard-to-produce recombinant proteins using either bacterial, yeast or mammalian expression systems. Feldan has also developed technical skills in medium scale production and in regulated production environment.Focus on Cell therapy
At the end of 2012, Feldan has decided to focus its core expertise towards the development and production of ancillary material for the regenerative medicine industry. This new orientation is a direct application of Feldan’s know-how in the production of high-quality recombinant proteins. This expertise allows Feldan to offer top-of-the-line proteins that are fully adapted to the needs of cell therapy developers.Development of the Feldan Shuttle
Since its beginning, Feldan has always valued internal research as an engine to generate value; with the development of the Feldan Shuttle in the later years, this vision is now coming true. The scientists at Feldan have uncovered a disruptive technology that allows the transition of protein-based therapies toward clinical trials. Along with the protein production platform, the Shuttle now allows Feldan to develop medical applications in-house as well as in collaboration with partners. This novel direction comes along with a new name (Feldan Therapeutics) and hints the multiple possibilities that lay ahead.